TECON BIOLOGYLTD Future Growth
Future criteria checks 3/6
TECON BIOLOGYLTD is forecast to grow earnings and revenue by 85.5% and 12.3% per annum respectively. EPS is expected to grow by 85.4% per annum. Return on equity is forecast to be 10.4% in 3 years.
Key information
85.5%
Earnings growth rate
85.4%
EPS growth rate
| Food earnings growth | 36.8% |
| Revenue growth rate | 12.3% |
| Future return on equity | 10.4% |
| Analyst coverage | Good |
| Last updated | 29 Apr 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 27,339 | 971 | N/A | 425 | 2 |
| 12/31/2025 | 23,949 | 1,303 | 761 | 829 | 8 |
| 12/31/2024 | 21,218 | 754 | -156 | 1,681 | 6 |
| 12/31/2023 | 18,057 | -735 | -1,049 | -700 | 6 |
| 9/30/2023 | 18,552 | -461 | 363 | 1,793 | N/A |
| 6/30/2023 | 17,686 | -48 | 155 | 1,497 | N/A |
| 3/31/2023 | 17,231 | 357 | -783 | 613 | N/A |
| 12/31/2022 | 16,732 | 302 | -1,102 | 328 | N/A |
| 9/30/2022 | 16,267 | -252 | -916 | -263 | N/A |
| 6/30/2022 | 15,803 | -1,042 | -2,308 | -984 | N/A |
| 3/31/2022 | 15,764 | -1,073 | -1,542 | 140 | N/A |
| 1/1/2022 | 15,711 | -703 | -219 | 1,533 | N/A |
| 9/30/2021 | 15,695 | 50 | -612 | 931 | N/A |
| 6/30/2021 | 15,200 | 1,128 | -512 | 1,083 | N/A |
| 3/31/2021 | 13,343 | 1,687 | -1,570 | -526 | N/A |
| 12/31/2020 | 11,987 | 1,720 | -1,531 | -601 | N/A |
| 9/30/2020 | 10,917 | 1,820 | -254 | 990 | N/A |
| 6/30/2020 | 9,465 | 1,398 | -157 | 988 | N/A |
| 3/31/2020 | 8,255 | 950 | -304 | 720 | N/A |
| 12/31/2019 | 7,476 | 644 | -1,046 | 307 | N/A |
| 9/30/2019 | 6,742 | 356 | -648 | 157 | N/A |
| 6/30/2019 | 5,701 | 286 | -1,600 | -673 | N/A |
| 3/31/2019 | 5,481 | 287 | -1,858 | -910 | N/A |
| 12/31/2018 | 5,273 | 314 | -1,771 | -1,178 | N/A |
| 9/30/2018 | 4,875 | 346 | -470 | 252 | N/A |
| 6/30/2018 | 4,647 | 325 | -167 | 473 | N/A |
| 3/31/2018 | 4,587 | 355 | -105 | 493 | N/A |
| 12/31/2017 | 4,630 | 407 | 64 | 649 | N/A |
| 9/30/2017 | 4,654 | 394 | 146 | 418 | N/A |
| 6/30/2017 | 4,550 | 390 | N/A | 343 | N/A |
| 3/31/2017 | 4,521 | 403 | N/A | 119 | N/A |
| 12/31/2016 | 4,444 | 393 | N/A | 316 | N/A |
| 9/30/2016 | 4,268 | 353 | N/A | 629 | N/A |
| 6/30/2016 | 4,260 | 297 | N/A | 626 | N/A |
| 3/31/2016 | 4,105 | 293 | N/A | 731 | N/A |
| 12/31/2015 | 4,167 | 246 | N/A | 512 | N/A |
| 9/30/2015 | 4,394 | 302 | N/A | 422 | N/A |
| 6/30/2015 | 4,488 | 274 | N/A | 625 | N/A |
| 3/31/2015 | 4,492 | 236 | N/A | 424 | N/A |
| 12/31/2014 | 4,236 | 236 | N/A | 501 | N/A |
| 9/30/2014 | 3,978 | 197 | N/A | 134 | N/A |
| 6/30/2014 | 3,823 | 201 | N/A | -106 | N/A |
| 3/31/2014 | 3,638 | 167 | N/A | 99 | N/A |
| 12/31/2013 | 3,725 | 170 | N/A | 91 | N/A |
| 9/30/2013 | 3,470 | 134 | N/A | 260 | N/A |
| 6/30/2013 | 3,437 | 118 | N/A | 267 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 002100 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.9%).
Earnings vs Market: 002100 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 002100 is expected to become profitable in the next 3 years.
Revenue vs Market: 002100's revenue (12.3% per year) is forecast to grow slower than the CN market (14.7% per year).
High Growth Revenue: 002100's revenue (12.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 002100's Return on Equity is forecast to be low in 3 years time (10.4%).